Literature DB >> 8530938

Early and severe sensory loss in three adult siblings with hexosaminidase A and B deficiency (Sandhoff disease).

H Schnorf1, R Gitzelmann, N U Bosshard, M Spycher, W Waespe.   

Abstract

Three siblings in their sixth and seventh decade with hexosaminidase A and B deficiency (adult form of GM2-gangliosidosis, variant O) developed early and severe sensory loss in addition to chronic motor neuron disease and cerebellar ataxia. Prominent mechanoallodynia was a manifesting symptom in two siblings. It is suggested that sensory deficits are due to a central-peripheral dying back axonopathy. The early and dominant sensory disturbances extend the clinical range of GM2-gangliosidosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530938      PMCID: PMC1073716          DOI: 10.1136/jnnp.59.5.520

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Adult (chronic) GM2 gangliosidosis. Atypical spinocerebellar degeneration in a Jewish sibship.

Authors:  I Rapin; K Suzuki; K Suzuki; M P Valsamis
Journal:  Arch Neurol       Date:  1976-02

2.  Chronic idiopathic ataxic neuropathy.

Authors:  M C Dalakas
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

3.  Juvenile spinal muscular atrophy: a new hexosaminidase deficiency phenotype.

Authors:  W G Johnson; H J Wigger; H R Karp; L M Glaubiger; L P Rowland
Journal:  Ann Neurol       Date:  1982-01       Impact factor: 10.422

Review 4.  The clinical aspects of adult hexosaminidase deficiencies.

Authors:  A Federico; S Palmeri; A Malandrini; G Fabrizi; M Mondelli; G C Guazzi
Journal:  Dev Neurosci       Date:  1991       Impact factor: 2.984

5.  Clinical and genetic variations in the syndrome of adult GM2 gangliosidosis resulting from hexosaminidase A deficiency.

Authors:  Z Argov; R Navon
Journal:  Ann Neurol       Date:  1984-07       Impact factor: 10.422

6.  Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.

Authors:  J Bayleran; P Hechtman; W Saray
Journal:  Clin Chim Acta       Date:  1984-11-15       Impact factor: 3.786

7.  Lysosomal enzymes in ataxia: discovery of two new cases of late onset hexosaminidase A and B deficiency (adult Sandhoff disease) in French Canadians.

Authors:  A Barbeau; L Plasse; T Cloutier; S Paris; M Roy
Journal:  Can J Neurol Sci       Date:  1984-11       Impact factor: 2.104

8.  Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytes.

Authors:  K Inui; D A Wenger
Journal:  Clin Genet       Date:  1984-10       Impact factor: 4.438

9.  Motor neuron disease and adult hexosaminidase A deficiency in two families: evidence for multisystem degeneration.

Authors:  H Mitsumoto; R J Sliman; I A Schafer; C S Sternick; B Kaufman; A Wilbourn; S J Horwitz
Journal:  Ann Neurol       Date:  1985-04       Impact factor: 10.422

10.  Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia: clinical, morphologic, and biochemical studies of nine cases.

Authors:  J P Willner; G A Grabowski; R E Gordon; A N Bender; R J Desnick
Journal:  Neurology       Date:  1981-07       Impact factor: 9.910

View more
  9 in total

1.  Peripheral and autonomic nervous system involvement in chronic GM2-gangliosidosis.

Authors:  M S Salman; J T Clarke; G Midroni; M B Waxman
Journal:  J Inherit Metab Dis       Date:  2001-02       Impact factor: 4.982

2.  Axonopathy is a compounding factor in the pathogenesis of Krabbe disease.

Authors:  Ludovico Cantuti Castelvetri; Maria Irene Givogri; Hongling Zhu; Benjamin Smith; Aurora Lopez-Rosas; Xi Qiu; Richard van Breemen; Ernesto Roque Bongarzone
Journal:  Acta Neuropathol       Date:  2011-03-04       Impact factor: 17.088

3.  Autosomal recessive adult onset ataxia.

Authors:  Nataša Dragašević-Mišković; Iva Stanković; Andona Milovanović; Vladimir S Kostić
Journal:  J Neurol       Date:  2021-09-09       Impact factor: 4.849

4.  Natural history of Tay-Sachs disease in sheep.

Authors:  Brett Story; Toloo Taghian; Jillian Gallagher; Jey Koehler; Amanda Taylor; Ashley Randle; Kayly Nielsen; Amanda Gross; Annie Maguire; Sara Carl; Siauna Johnson; Deborah Fernau; Elise Diffie; Paul Cuddon; Carly Corado; Sundeep Chandra; Miguel Sena-Esteves; Edwin Kolodny; Xuntian Jiang; Douglas Martin; Heather Gray-Edwards
Journal:  Mol Genet Metab       Date:  2021-08-21       Impact factor: 4.204

Review 5.  Peripheral neuropathy and inborn errors of metabolism in adults.

Authors:  F Sedel; C Barnerias; O Dubourg; I Desguerres; O Lyon-Caen; Jean-Marie Saudubray
Journal:  J Inherit Metab Dis       Date:  2007-09-21       Impact factor: 4.982

6.  Quantitative oculomotor and nonmotor assessments in late-onset GM2 gangliosidosis.

Authors:  Christopher D Stephen; David Balkwill; Peter James; Elizabeth Haxton; Kenneth Sassower; Jeremy D Schmahmann; Florian Eichler; Richard Lewis
Journal:  Neurology       Date:  2020-01-21       Impact factor: 9.910

7.  Peripheral neuropathy in a family with Sandhoff disease and SH3TC2 deficiency.

Authors:  Christopher Grunseich; Alice B Schindler; Ke-Lian Chen; Dara Bakar; Ami Mankodi; Ryan Traslavina; Abhik Ray-Chaudhury; Tanya J Lehky; Eva H Baker; Nicholas J Maragakis; Cynthia J Tifft; Kenneth H Fischbeck
Journal:  J Neurol       Date:  2015-03-04       Impact factor: 4.849

Review 8.  Genetics and Therapies for GM2 Gangliosidosis.

Authors:  Maria Begona Cachon-Gonzalez; Eva Zaccariotto; Timothy Martin Cox
Journal:  Curr Gene Ther       Date:  2018       Impact factor: 4.391

9.  The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment.

Authors:  Camilo Toro; Mosufa Zainab; Cynthia J Tifft
Journal:  Neurosci Lett       Date:  2021-08-25       Impact factor: 3.046

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.